MAINZ BIOMED B V's ticker is and the CUSIP is N5436L101. A total of 9 filers reported holding MAINZ BIOMED B V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,000 | -38.8% | 13,909 | -1.8% | 0.03% | -37.3% |
| Q2 2023 | $67,000 | -24.7% | 14,159 | -0.7% | 0.05% | -25.0% |
| Q1 2023 | $89,000 | +88018.8% | 14,259 | 0.0% | 0.07% | -16.0% |
| Q4 2022 | $101 | -99.9% | 14,259 | -3.2% | 0.08% | +2.5% |
| Q3 2022 | $101,000 | -25.7% | 14,724 | 0.0% | 0.08% | -18.6% |
| Q2 2022 | $136,000 | -36.7% | 14,724 | 0.0% | 0.10% | -24.8% |
| Q1 2022 | $215,000 | – | 14,724 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenwich Investment Management, Inc. | 13,909 | $41,000 | 0.03% |
| UBS Group AG | 98 | $286 | 0.00% |
| NewEdge Advisors, LLC | 1,000 | $2,920 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $584 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 673 | $1,965 | 0.00% |
| MORGAN STANLEY | 200 | $584 | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,500 | $4,380 | 0.00% |
| JPMORGAN CHASE & CO | 2,569 | $7,501 | 0.00% |